Indications and uses
Helps prevent sunburn. If used as directed with other sun protection measures (see other information), decreases the risk of skin cancer and early skin aging caused by the sun.
SPF-30 SPORT moisturizer
- Manufacturer
- Juice Beauty
- Effective date
- 2013-09-05
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:36:50
Label at a glance#
ProductSPF-30 SPORT moisturizer
Active ingredientZinc Oxide
Label structure10 sections
Dosage and administration
Due to the nature of mineral formulations, separation may occur. Shake tube before use. Apply a smooth, even layer to face, neck and top of hands before sun exposure and as needed. Children under 6 months of age, ask a doctor.
Storage and handling
Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures incluing: Limit time in the sun, especially from 10 a.m. – 2 p.m. Wear long-sleeved shirts, pants, hats and sunglasses.
Contacts and useful links#
Websitewww.juicebeauty.com
www.juicebeauty.com
www.juicebeauty.comLabel contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
Active Ingredient
Zinc Oxide 20%
Purpose
Sunscreen
Uses
- Helps prevent sunburn.
- If used as directed with other sun protection measures (see other information), decreases the risk of skin cancer and early skin aging caused by the sun.
Warnings
For external use only
OTC - WHEN USING SECTION
- When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash or irritation develops and lasts.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
- Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
Due to the nature of mineral formulations, separation may occur. Shake tube before use. Apply a smooth, even layer to face, neck and top of hands before sun exposure and as needed. Children under 6 months of age, ask a doctor.
Other Information
Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures incluing:
Limit time in the sun, especially from 10 a.m. – 2 p.m. Wear long-sleeved shirts, pants, hats and sunglasses.
Inactive Ingredients
Organic juices of aloe barbadensis (organic aloe juice)1, pyrus malus (organic apple juice)1, vitis vinifera (organic white grape juice)1, cocos nucifera (organic coconut oil)1, caprylic/capric triglycerides, sorbitan stearate, ricinus communis (castor seed oil), hydrogenated methyl abietate, polyglyceryl-10 laurate, magnesium sulfate, helianthus annuus (organic sunflower seed oil)1, simmondsia chinensis (organic jojoba seed oil)1, tocopherol (Vitamin E), magnesium ascorbyl phosphate (Vitamin C), citrus limonum (lemon extract), iron oxides, phenethyl alcohol, ethylhexylglycerin, citrus reticulata (mandarin) & citrus aurantium (petitgrain) pure essential oils.
1 certified organic ingredient
Questions?
PRINCIPAL DISPLAY PANEL - 110 mL Tube Label
SPORT
juice
BEAUTY®
THE ORGANIC SOLUTION™
SPF 30 Sport
Moisturizer
MADE WITH
CERTIFIED
ORGANIC
INGREDIENTS
Water Resistant
(80 minutes)
Antioxidant Rich
3.75 fl oz e 110 mL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55165-0104-1 | 2019-11-27 | C162847 | 48780-1 | 9855d018-ebee-cd31-e053-dbdaa90ab51a | SPF-30 SPORT moisturizer |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55165-0104-1 | SPF-30 SPORT moisturizer | 110 mL in 1 TUBE | LOTION | 110 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55165-0104 | SPF-30 SPORT MOISTURIZER (ZINC OXIDE) LOTION [JUICE BEAUTY] | 1 | Legacy NDC, 1 package rows | 20130906_19e06c07-5b52-4576-951f-c77da93e61bc.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| Zinc Oxide | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| aloe vera leaf | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| apple juice | INACTIVE INGREDIENT | 9871T0PD5P | 1 | |
| citrus aurantium leafy twig oil | INACTIVE INGREDIENT | 5K6H1IMT3D | 1 | |
| coconut oil | INACTIVE INGREDIENT | Q9L0O73W7L | 1 | |
| ethylhexylglycerin | INACTIVE INGREDIENT | 147D247K3P | 1 | |
| ferric oxide red | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| jojoba oil | INACTIVE INGREDIENT | 724GKU717M | 1 | |
| MAGNESIUM ASCORBYL PHOSPHATE | INACTIVE INGREDIENT | 0R822556M5 | 1 | |
| magnesium sulfate | INACTIVE INGREDIENT | DE08037SAB | 1 | |
| mandarin oil | INACTIVE INGREDIENT | NJO720F72R | 1 | |
| medium-chain triglycerides | INACTIVE INGREDIENT | C9H2L21V7U | 1 | |
| phenylethyl alcohol | INACTIVE INGREDIENT | ML9LGA7468 | 1 | |
| polyglyceryl-10 laurate | INACTIVE INGREDIENT | MPJ2Q8WI8G | 1 | |
| sorbitan monostearate | INACTIVE INGREDIENT | NVZ4I0H58X | 1 | |
| sunflower oil | INACTIVE INGREDIENT | 3W1JG795YI | 1 | |
| tocopherol | INACTIVE INGREDIENT | R0ZB2556P8 | 1 |
Products#
Every source-derived product name is available through these pages.
- SPF-30 SPORT moisturizer
- Zinc Oxide
- apple juice
- aloe vera leaf
- coconut oil
- medium-chain triglycerides
- sorbitan monostearate
- polyglyceryl-10 laurate
- magnesium sulfate
- sunflower oil
- jojoba oil
- tocopherol
- MAGNESIUM ASCORBYL PHOSPHATE
- ferric oxide red
- phenylethyl alcohol
- ethylhexylglycerin
- mandarin oil
- citrus aurantium leafy twig oil
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55165-0104 | 55165-0104-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| coconut oil | COCONUT OIL | Q9L0O73W7L | OINTMENT / TOPICAL | 14.75 %w/w | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, EXTENDED RELEASE / ORAL | 5 mg | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | DROPS / ORAL | NA | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | LOTION / TOPICAL | 7 %w/w | ||
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | SUSPENSION / ORAL | 62.5 mg/5ml | ||
| coconut oil | COCONUT OIL | Q9L0O73W7L | SOAP / TOPICAL | 4.6 %w/w | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | SUSPENSION, EXTENDED RELEASE / ORAL | 2.7 mg | ||
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | TABLET / ORAL | 4 mg | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | CAPSULE / ORAL | 4771 mg | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | LOTION / TOPICAL | NA | ||
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | SPRAY / TOPICAL | 4.58 %w/w | ||
| coconut oil | COCONUT OIL | Q9L0O73W7L | SOLUTION / TOPICAL | 15.5 %w/w | ||
| magnesium sulfate | MAGNESIUM SULFATE | DE08037SAB | SOAP / TOPICAL | 0.2 %w/w | ||
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | SUPPOSITORY / VAGINAL | NA | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, COATED PELLETS / ORAL | 2 mg | ||
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | AEROSOL, FOAM / TOPICAL | 0.55 %w/w | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, COATED / ORAL | 1 mg | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE / ORAL | 5 mg | ||
| tocopherol | TOCOPHEROL | R0ZB2556P8 | CREAM / TOPICAL | NA | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SPRAY, METERED / SUBLINGUAL | 110 mg | ||
| phenylethyl alcohol | PHENYLETHYL ALCOHOL | ML9LGA7468 | SPRAY / NASAL | 1 mg | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, DELAYED RELEASE / ORAL | 37 mg | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | TABLET / SUBLINGUAL | 1 mg | ||
| tocopherol | TOCOPHEROL | R0ZB2556P8 | TABLET / ORAL | 0.08 mg | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | FILM, EXTENDED RELEASE / TRANSDERMAL | NA | ||
| phenylethyl alcohol | PHENYLETHYL ALCOHOL | ML9LGA7468 | CREAM / TOPICAL | NA | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | TABLET / BUCCAL | 0.4 mg | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | AEROSOL, FOAM / TOPICAL | 10.87 %w/w | ||
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | LOTION / TOPICAL | 89 mg | ||
| coconut oil | COCONUT OIL | Q9L0O73W7L | CAPSULE, LIQUID FILLED / ORAL | NA | ||
| coconut oil | COCONUT OIL | Q9L0O73W7L | TABLET / ORAL | NA | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 3.6 mg | ||
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | OINTMENT / TOPICAL | NA | ||
| tocopherol | TOCOPHEROL | R0ZB2556P8 | CAPSULE / ORAL | NA | ||
| phenylethyl alcohol | PHENYLETHYL ALCOHOL | ML9LGA7468 | SOLUTION / AURICULAR (OTIC) | 0.25 %w/w | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SOLUTION / ORAL | 5566 mg | ||
| magnesium sulfate | MAGNESIUM SULFATE | DE08037SAB | TABLET, FILM COATED / ORAL | 14 mg | ||
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | SUSPENSION / TOPICAL | 2.15 %w/w | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | 990.3 mg | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, ORALLY DISINTEGRATING / ORAL | 2 mg | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | CREAM / TOPICAL | 3300 mg | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | POWDER / SUBLINGUAL | 2 mg | ||
| phenylethyl alcohol | PHENYLETHYL ALCOHOL | ML9LGA7468 | SUSPENSION / INTRAMUSCULAR | 5 mg | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | INJECTION, EMULSION / INTRAVENOUS | 1.1 %w/v | ||
| magnesium sulfate | MAGNESIUM SULFATE | DE08037SAB | TABLET, COATED / ORAL | NA | ||
| phenylethyl alcohol | PHENYLETHYL ALCOHOL | ML9LGA7468 | SOLUTION / OPHTHALMIC | 0.25 %w/w | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, CHEWABLE / ORAL | 2 mg | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 0.15 mg | ||
| phenylethyl alcohol | PHENYLETHYL ALCOHOL | ML9LGA7468 | CREAM / VAGINAL | NA | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | TABLET / ORAL | 2 mg | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, COATED / ORAL | 0.12 mg | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | POWDER, FOR SUSPENSION / ORAL | 1 mg | ||
| magnesium sulfate | MAGNESIUM SULFATE | DE08037SAB | CAPSULE / ORAL | NA | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | POWDER, FOR SUSPENSION / ORAL | 3390 mg/5ml | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | OINTMENT / TOPICAL | 20 %w/w | ||
| tocopherol | TOCOPHEROL | R0ZB2556P8 | CAPSULE, COATED / ORAL | 0.25 mg | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | GEL / TOPICAL | 12 mg | ||
| sorbitan monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | CREAM / TOPICAL | 177 mg | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | TABLET / ORAL | 8 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 5dfdc506-d989-47aa-8104-23b7421d1e4b | 19e06c07-5b52-4576-951f-c77da93e61bc | 2013-09-05 | Warnings | 5dfdc506-d989-47aa-8104-23b7421d1e4b 19e06c07-5b52-4576-951f-c77da93e61bc |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.